These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 18946055)

  • 41. The effect of apoE genotype and sex on ApoE plasma concentration is determined by dietary fat in healthy subjects.
    Moreno JA; Pérez-Jiménez F; Moreno-Luna R; Pérez-Martínez P; Fuentes-Jiménez F; Marín C; Portugal H; Lairon D; López-Miranda J
    Br J Nutr; 2009 Jun; 101(12):1745-52. PubMed ID: 19025720
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein.
    Kappelle PJ; Zwang L; Huisman MV; Banga JD; Sluiter WJ; Dallinga-Thie GM; Dullaart RP
    Expert Opin Ther Targets; 2009 Jul; 13(7):743-51. PubMed ID: 19505224
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and safety of combination of extended release niacin and atorvastatin in patients with low levels of high density lipoprotein cholesterol.
    Harikrishnan S; Rajeev E; Tharakan JA; Titus T; Ajit Kumar VK; Sivasankaran S; Krishnamoorthy KM; Nair K
    Indian Heart J; 2008; 60(3):215-22. PubMed ID: 19240310
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metabolic response of soy pinitol on lipid-lowering, antioxidant and hepatoprotective action in hamsters fed-high fat and high cholesterol diet.
    Choi MS; Lee MK; Jung UJ; Kim HJ; Do GM; Park YB; Jeon SM
    Mol Nutr Food Res; 2009 Jun; 53(6):751-9. PubMed ID: 19205001
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Brazil nut ingestion increased plasma selenium but had minimal effects on lipids, apolipoproteins, and high-density lipoprotein function in human subjects.
    Strunz CC; Oliveira TV; Vinagre JC; Lima A; Cozzolino S; Maranhão RC
    Nutr Res; 2008 Mar; 28(3):151-5. PubMed ID: 19083402
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A pinch of niacin raises HDL.
    Harv Heart Lett; 2002 Jun; 12(10):7. PubMed ID: 12079824
    [No Abstract]   [Full Text] [Related]  

  • 47. A Translational Medicine perspective of the development of torcetrapib: Does the failure of torcetrapib development cast a shadow on future development of lipid modifying agents, HDL elevation strategies or CETP as a viable molecular target for atherosclerosis? A case study of the use of biomarkers and Translational Medicine in atherosclerosis drug discovery and development.
    Zhao L; Jin W; Rader D; Packard C; Feuerstein G
    Biochem Pharmacol; 2009 Aug; 78(4):315-25. PubMed ID: 19539799
    [TBL] [Abstract][Full Text] [Related]  

  • 48. When HDL gets fat..
    Brown RJ; Rader DJ
    Circ Res; 2008 Jul; 103(2):131-2. PubMed ID: 18635830
    [No Abstract]   [Full Text] [Related]  

  • 49. Carbohydrate intake, serum lipids and apolipoprotein E phenotype show association in children.
    Ruottinen S; Rönnemaa T; Niinikoski H; Lagström H; Saarinen M; Pahkala K; Kaitosaari T; Viikari J; Simell O
    Acta Paediatr; 2009 Oct; 98(10):1667-73. PubMed ID: 19563454
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The modern art of atherosclerosis: a picture of colorful plants, cholesterol, and inflammation.
    Frolov A; Hui DY
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):450-2. PubMed ID: 17301323
    [No Abstract]   [Full Text] [Related]  

  • 51. Fat, lipotropes, hypolipidemic agents and liver cancer.
    Shinozuka H; Katyal SL; Perera MI
    Prog Clin Biol Res; 1986; 222():461-86. PubMed ID: 3024174
    [No Abstract]   [Full Text] [Related]  

  • 52. Cholesteryl ester transfer protein inhibition for coronary heart disease prevention: real hope or despair?
    Frishman WH; Barkowski RS
    Am J Med; 2008 Aug; 121(8):644-6. PubMed ID: 18691473
    [No Abstract]   [Full Text] [Related]  

  • 53. [Reduced prevalence of dementia in patients treated with antilipemic agents. An overview of cholesterol metabolism in the brain and actions].
    Carlson LA; Winblad B
    Lakartidningen; 2001 Sep; 98(36):3795-7. PubMed ID: 11586810
    [No Abstract]   [Full Text] [Related]  

  • 54. Morphing the topography of atherosclerosis: an unexpected role for PECAM-1.
    Cybulsky MI
    Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):1887-9. PubMed ID: 18946053
    [No Abstract]   [Full Text] [Related]  

  • 55. Case 40-2006: anemia and low HDL cholesterol.
    Goldberg RB; Mendez AJ
    N Engl J Med; 2007 May; 356(18):1893-5; author reply 1893-5. PubMed ID: 17479486
    [No Abstract]   [Full Text] [Related]  

  • 56. Genetic determinants of dietary and drug responsiveness.
    Karpe F
    Proc Nutr Soc; 2000 Aug; 59(3):437-8. PubMed ID: 10997669
    [No Abstract]   [Full Text] [Related]  

  • 57. Low HDL cholesterol levels.
    Xie Y; Davidson NO
    N Engl J Med; 2006 Jan; 354(4):417-9; author reply 417-9. PubMed ID: 16444811
    [No Abstract]   [Full Text] [Related]  

  • 58. [The usefulness of kinetic studies and modeling in the study of apolipoprotein metabolism].
    Malmendier CL
    Bull Acad Natl Med; 1985 Jun; 169(6):735-45. PubMed ID: 3910175
    [No Abstract]   [Full Text] [Related]  

  • 59. HDL kinetics, fish oils and diabetes.
    Barrett PH; Watts GF
    Atherosclerosis; 2001 Nov; 159(1):243-4. PubMed ID: 11689229
    [No Abstract]   [Full Text] [Related]  

  • 60. Is the cholesteryl ester transfer protein proatherogenic or antiatherogenic in humans?
    Cuchel M; Rader DJ
    J Am Coll Cardiol; 2007 Nov; 50(20):1956-8. PubMed ID: 17996560
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.